Literature DB >> 6785350

The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.

J Mann, R O'Brien, M K Hostetter, C A Alper, F S Rosen, B M Babior.   

Abstract

A complement- (C) fixing particle consisting of agarose beads to which 5-thioglucose was attached by a --S--S-- bond (agarose-thioglucose) was employed to investigate the mechanism of attachment of C3 to surfaces. When whole serum containing [125I] C3 was incubated with agarose-thioglucose, labeled C3b was taken up in a form that was not removed by 2 M NaCl but was released by 10 mM dithiothreitol. Deposition of DTT-releasable C3b was dependent upon the alternative pathway of C activation. Gel electrophoresis of DTT-releasable C3b from similar experiments performed with unlabeled serum and agarose-[3H]thioglucose showed that the liberated C3b contained a molecule of radioactive thioglucose attached to the alpha'-chain by a covalent bond that was stable to mercaptoethanol. We propose that the thioglucose-alpha' chain bond was formed during the course of C activation by a reaction between the "labile binding site" of newly released C3b and the (then) particle-bound sugar. This formulation implies that the reaction by which C3b attaches to 5-thioglucose in this system is the reaction responsible for opsonization by C3b, and that the C3b-linked sugar represents a marker for the labile binding site. Incubation of the particle-bound C3b in serum resulted in the cleavage of the covalently linked alpha'-chain to several smaller polypeptides, the major cleavage product having a m.w. of 70,000.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785350

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

2.  C3b acceptors on human peripheral blood mononuclear cells; characterization and functional role.

Authors:  A Erdei; G Füst; J Gyenes; Z Fábry; J Gergely
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

3.  A general method for affinity purification of complement component C3b using factor H-sepharose.

Authors:  J D Scott; J E Fothergill
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

4.  Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.

Authors:  T Hidvégi; G Füst; E Rajnavölgyi; J Kulics; J Gergely
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

5.  Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.

Authors:  Pamela S Hair; Charlene G Echague; Reuben D Rohn; Neel K Krishna; Julius O Nyalwidhe; Kenji M Cunnion
Journal:  J Transl Med       Date:  2012-03-05       Impact factor: 5.531

6.  Associations of dicarbonyl stress with complement activation: the CODAM study.

Authors:  Ying Xin; Elisabeth Hertle; Carla J H van der Kallen; Casper G Schalkwijk; Coen D A Stehouwer; Marleen M J van Greevenbroek
Journal:  Diabetologia       Date:  2020-01-28       Impact factor: 10.122

7.  gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes.

Authors:  K Joiner; S Hieny; L V Kirchhoff; A Sher
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.